Iterum Therapeutics plc (ITRM)

NASDAQ

$--

(--)

Market Closed

Iterum Therapeutics plc (ITRM) Live Price Chart

Last updated: ⁦2026-10-23 00:56:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Iterum Therapeutics plc (ITRM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Iterum Therapeutics plc (ITRM) Latest Closing Stock Price

Iterum Therapeutics plc (ITRM) last closed at $-- as of --, -- from the previous close of $--.

During the latest regular trading session, ITRM traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.

Iterum Therapeutics plc (ITRM) 7-Day Stock Price Change

Over the past seven days, Iterum Therapeutics plc (ITRM) moved from $0.16 to $0.03, representing a decline of 81.10% ($0.13).

The stock traded between $0.03 and $0.18 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 134.70 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Iterum Therapeutics plc (ITRM)?

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Iterum Therapeutics plc Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	9
Exchange	NASDAQ
Company Website	https://www.iterumtx.com

How to Buy Iterum Therapeutics plc (ITRM) Stock on MEXC

Eligible investors can buy real shares of Iterum Therapeutics plc (ITRM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ITRM and Place Your Order

Open the RealStocks trading page and search for ITRM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Iterum Therapeutics plc (ITRM) stock price today?

Iterum Therapeutics plc (ITRM) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is ITRM stock going up or down today?

As of --, ITRM is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is ITRM pre-market price?

As of --, ITRM is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ITRM after-hours price?

As of --, ITRM is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ITRM stock trading now?

ITRM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ITRM sit relative to its 52-week high and low?

Over the past 52 weeks, ITRM has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Iterum Therapeutics plc in?

Iterum Therapeutics plc (ITRM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Iterum Therapeutics plc's market capitalization and where is it listed?

Iterum Therapeutics plc is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ITRM valued in terms of P/E ratio and EPS?

ITRM trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Iterum Therapeutics plc pay a dividend?

Iterum Therapeutics plc pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.